CJASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published ahead of print on August 16, 2007
Clin J Am Soc Nephrol 2: 1073-1078, 2007
© 2007 American Society of Nephrology
doi: 10.2215/CJN.00290107

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
CJN.00290107v1
2/5/1073    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bleyer, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bleyer, A. J.

Diagnostic and Therapeutic Corner

Use of Antimicrobial Catheter Lock Solutions to Prevent Catheter-Related Bacteremia

Anthony J. Bleyer

Section on Nephrology, Wake Forest University School of Medicine, Winston Salem, North Carolina

Address correspondence to: Dr. Anthony J. Bleyer, Section on Nephrology, Wake Forest University School of Medicine, Medical Center Boulevard, Winston Salem, NC 27157. Phone: 336-716-4513; Fax: 336-716-4318; E-mail: ableyer{at}wfubmc.edu

Catheter-related bacteremia is an important source of morbidity and mortality in hemodialysis patients. A number of well-designed, controlled, prospective trials using antimicrobial catheter lock solutions to prevent catheter-related bacteremia have shown a dramatic, statistically significant decrease in not only infection but also mortality related to catheter-related bacteremia. Despite evidence of significant benefit, these locks are not routinely used in the United States. This review describes the epidemic problem of catheter-related bacteremia, reviews recent clinical trials with antimicrobial catheter lock solutions, and discusses current options and potential indications for catheter lock solutions in the hemodialysis population.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
J. Steczko, S. R. Ash, D. E. Nivens, L. Brewer, and R. K. Winger
Microbial inactivation properties of a new antimicrobial/antithrombotic catheter lock solution (citrate/methylene blue/parabens)
Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1937 - 1945.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
L. Labriola, R. Crott, and M. Jadoul
Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials
Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1666 - 1672.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Society of Nephrology.